NCT05533294View on ClinicalTrials.gov

Study of ARO-RAGE in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

February 8, 2024

Study Completion Date

February 8, 2024

Conditions
Asthma
Interventions
DRUG

ARO-RAGE Injection

ARO-RAGE injection for sc administration

DRUG

Placebo

normal saline (0.9% NaCl) by sc injection

Trial Locations (1)

1010

Research Site, Grafton

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY